Lesinurad Impurity 1 | CAS 1533519-92-4 - Request Quote
Lesinurad Impurity 1
| SZ CAT No: | SZ-L109008 |
| CAS No | 1533519-92-4 |
| Mol.F. | C13H13N : HCl |
| Mol.Wt. | 183.3 : 36.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 878671-94-4 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lesinurad Impurity 1 is chemically 4-Cyclopropylnaphthalen-1-amine hydrochloride. Lesinurad Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Lesinurad Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lesinurad.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1533519-92-4
Purchase 1533519-92-4
Order 1533519-92-4
Enquire 1533519-92-4
price of 1533519-92-4
1533519-92-4 Supplier
1533519-92-4 Manufacturer
1533519-92-4 Exporter
buy high quality Lesinurad Impurity 1
Purchase Lesinurad Impurity 1
Lesinurad Impurity 1 suppliers
Lesinurad Impurity 1 manufacturers
Lesinurad Impurity 1 price
Order Lesinurad Impurity 1
Enquire Lesinurad Impurity 1
Lesinurad Impurity 1 cost
Lesinurad Impurity 1 Supplier
Lesinurad Impurity 1 Distributor
Lesinurad Impurity 1 for Method Validation
Lesinurad Reference Standard
Lesinurad Impurity 1 for ANDA Filing
Lesinurad Impurity 1 for Forced Degradation Studies
Lesinurad Impurity 1 Identification Standards
Lesinurad Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.